Search Results - "Henriksson, R."

Refine Results
  1. 1
  2. 2

    The dynorphin/κ-opioid receptor system and its role in psychiatric disorders by Tejeda, H. A., Shippenberg, T. S., Henriksson, R.

    “…The dynorphin/κ-opioid receptor system has been implicated in the pathogenesis and pathophysiology of several psychiatric disorders. In the present review, we…”
    Get full text
    Journal Article
  3. 3

    Age and surgical outcome of low‐grade glioma in Sweden by Corell, A., Carstam, L., Smits, A., Henriksson, R., Jakola, A. S.

    Published in Acta neurologica Scandinavica (01-10-2018)
    “…Background Low‐grade gliomas (LGG) are slow‐growing primary brain tumors that typically affect young adults. Advanced age is widely recognized as a poor…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7

    Expression of LRIG1 is associated with good prognosis and human papillomavirus status in oropharyngeal cancer by Lindquist, D, Näsman, A, Tarján, M, Henriksson, R, Tot, T, Dalianis, T, Hedman, H

    Published in British journal of cancer (01-04-2014)
    “…Background: The incidence of human papillomavirus (HPV)-associated oropharyngeal cancer has increased rapidly during the past decades. HPV is typically…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Effects of tropical open-water seaweed farming on seagrass ecosystem structure and function by Eklöf, J. S., Henriksson, R., Kautsky, N.

    “…Seaweed farming is often depicted as a sustainable form of aquaculture, but suspected habitat alterations and spread of algae outside farms have rendered…”
    Get full text
    Journal Article
  10. 10

    O9.03 BRAIN TUMORS IN SWEDEN: DATA FROM A POPULATION BASED REGISTRY 1999-2012 by Asklund, T., Malmstrom, A., Bergqvist, M., Bjor, O., Henriksson, R.

    Published in Neuro-oncology (Charlottesville, Va.) (01-09-2014)
    “…BACKGROUND: The annual incidence of adult patients diagnosed with a high grade glioma (WHO grade III-IV) is approximately 400 in Sweden. The corresponding…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse by Brada, M., Hoang-Xuan, K., Rampling, R., Dietrich, P-Y., Dirix, L. Y., Macdonald, D., Heimans, J. J., Zonnenberg, B. A., Bravo-Marques, J. M., Henriksson, R., Stupp, R., Yue, N., Bruner, J., Dugan, M., Rao, S., Zaknoen, S.

    Published in Annals of oncology (01-02-2001)
    “…Background: Recurrent glioblastoma multiforme (GBM) is resistant to most therapeutic endeavors, with low response rates and survival rarely exceeding six…”
    Get full text
    Journal Article
  13. 13

    Vascular endothelial growth factor is of high prognostic value in node-negative breast carcinoma by Linderholm, B, Tavelin, B, Grankvist, K, Henriksson, R

    Published in Journal of clinical oncology (01-09-1998)
    “…The prognostic value of vascular endothelial growth factor (VEGF) protein, known to stimulate endothelial growth and angiogenesis, was evaluated in…”
    Get more information
    Journal Article
  14. 14
  15. 15

    P16.02 ADC TEXTURE - AN IMAGING BIOMARKER FOR HIGH GRADE GLIOMA? by Asklund, T., Birgander, R., Brynolfsson, P., Garpebring, A., Hauksson, J., Henriksson, R., Karlsson, M., Nilsson, D., Nyholm, T., Trygg, J.

    Published in Neuro-oncology (Charlottesville, Va.) (01-09-2014)
    “…INTRODUCTION: Median survival for high grade gliomas is limited, at least partly explained by intratumoral heterogeneity contributing to treatment resistance…”
    Get full text
    Journal Article
  16. 16

    LRIG1 and epidermal growth factor receptor in renal cell carcinoma: a quantitative RT-PCR and immunohistochemical analysis by THOMASSON, M, HEDMAN, H, GUO, D, LJUNGBERG, B, HENRIKSSON, R

    Published in British journal of cancer (06-10-2003)
    “…In all, 31 renal cell carcinomas (RCCs) were examined for expression of the potential tumour suppressor LRIG1 (formerly Lig-1) and the epidermal growth factor…”
    Get full text
    Journal Article
  17. 17

    Genetic variations in VEGF and VEGFR2 and glioblastoma outcome by Sjöström, S., Wibom, C., Andersson, U., Brännström, T., Broholm, H., Johansen, C., Collatz-Laier, H., Liu, Y., Bondy, M., Henriksson, R., Melin, B.

    Published in Journal of neuro-oncology (01-09-2011)
    “…Vascular endothelial growth factor (VEGF) and its receptors (VEGFR) are central components in the development and progression of glioblastoma. To investigate…”
    Get full text
    Journal Article
  18. 18

    LRIG1 and squamous epithelial uterine cervical cancer: correlation to prognosis, other tumor markers, sex steroid hormones, and smoking by Lindström, A K, Ekman, K, Stendahl, U, Tot, T, Henriksson, R, Hedman, H, Hellberg, D

    “…The aim is to evaluate LRIG1 as a prognosis predictor and correlations to cofactors in squamous cell cervical cancer. LRIG1 expression was studied in 128…”
    Get more information
    Journal Article
  19. 19
  20. 20